Evidence map›Paper›PMID 39205432›Full record

ArticleDrug and alcohol review2024

"You might be nice, but where you take me, they're not gonna be": Preferences for field-based post-overdose interventions.

Jenna van Draanen, Addy Adwell, Courteney Wettemann, Callan Elswick Fockele, Brenda Goh, David L Perlmutter, Grover Will Williams, Nathan Holland, Tessa Frohe

Abstract read
In one paragraph

Article in Drug and alcohol review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Developing Longitudinal Post-Overdose Care: A Call to Action.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Article
  2. Medical Toxicology is the Overdose Specialty: Implications for the Dimensions and Continuum of Overdose Care.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Article
  3. Assessment of a County-Wide, Pan-First Responder Take-Home Naloxone Program in Denver, Colorado.Journal of the American College of Emergency Physicians open · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jenna van DraanenDepartment of Child, Family, and Population Health Nursing, University of Washington, Seattle, USA.ORCID 0000-0003-0486-6525
Addy AdwellDepartment of Child, Family, and Population Health Nursing, University of Washington, Seattle, USA.
Courteney WettemannDepartment of Child, Family, and Population Health Nursing, University of Washington, Seattle, USA.
Callan Elswick FockeleDepartment of Emergency Medicine, University of Washington, Seattle, USA.
Brenda GohDepartment of Health Systems and Population Health, University of Washington, Seattle, USA.
David L PerlmutterDepartment of Health Systems and Population Health, University of Washington, Seattle, USA.ORCID 0009-0003-5061-6209
Grover Will WilliamsResearch with Expert Advisors on Drug Use, Seattle, USA.
Nathan HollandResearch with Expert Advisors on Drug Use, Seattle, USA.
Tessa FroheDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA.

Funding

eHaRT-A: Adapting an evidence-based, in-person harm reduction treatment into a virtual care telehealth intervention for people with lived experience of homelessness and alcohol use disorderK01AA030053 · NIAAA · UNIVERSITY OF WASHINGTON · PI Tessa Marie Frohe · 2022 to 2026
$861k
NIAAA NIH HHS K01 AA030053University of Washington Implementation Science Program Pilot Grant
6 · The paper itself

Abstract

introductionEmergency medical services (EMS) systems are piloting interventions to respond to overdoses with additional services such as leave-behind naloxone and medication for opioid use disorder, but little is known about the perspectives of people who use drugs (PWUD) on these interventions being delivered by EMS during an overdose response.

methodsThe Consolidated Framework for Implementation Research guided the development of data collection tools, the analytic strategy and the organisation of results. A community engaged method was used which included both academically trained researchers and community trained researchers who are also PWUD. This study used semi-structured interviews to gather data from 13 PWUD in King County, Washington in June 2022. Data were analysed using thematic analysis.

resultsThe people interviewed for this study viewed EMS distribution of leave-behind naloxone and field-based buprenorphine favourably. They viewed EMS facilitation of hepatitis C virus and HIV testing in the field less favourably and were concerned about stigmas associated with those results. Additional themes emerged regarding: the need for different approaches to post-overdose care; the need for new services, including post-overdose trauma counselling and an alternative destination to the emergency department; and the harms of law enforcement presence at overdose responses. DISCUSSION AND

conclusionsThis study found strong support for leave-behind naloxone and field-initiated buprenorphine. Further training for EMS should include trauma-informed care and strategies to address burnout and increase compassion. Alternatives to the emergency department as a post-overdose destination are needed. These strategies should be considered by jurisdictions revising overdose response protocols.

Indexed as

Drug OverdoseEmergency Medical ServicesNaloxoneNarcotic AntagonistsAdultBuprenorphineDrug UsersFemaleHumansMaleMiddle AgedOpioid-Related DisordersBuprenorphineNaloxoneNarcotic Antagonistsdrug overdoseemergency careemergency medical serviceprehospitalsubstance use disorder

Identifiers

PMID39205432
PMCPMC12372593

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.